Order-of-magnitude gap: the company is already serving a demand source whose scale dwarfs its own current business
The model's full reasoning — Q3 2018 call → NOWe need to determine if management describes a mismatch of scale between the company and the demand it is already serving. The key is: the company is already inside a large flow, and management explicitly draws the size contrast, treating it as a point. Looking at the transcript: Sam Landy says "Our ability to identify and acquire value-add communities... has resulted in exceptional income and earnings growth." He mentions "We currently have approximately 3,600 vacant sites, most of which were acquired. This vacancy factor provides us with a significant runway to improve upon our already successful business plan." That's about vacant sites, not a large external flow. He talks about sales: "Sales for the quarter were $4.7 million, as compared to $2.8 million last year, representing an increase of 67%." And "We are encouraged by this dramatic increase in sales and believe this portion of our business could be a major profit center for years to come." That's about growth, not a mismatch of scale. He mentions "The conventional housing market is slowing down, because of high prices and rising interest rates. As the cost of conventional housing increases, our product becomes more advantageous to the consumer, driving increased sales and better margins." That's about market conditions, not a specific large flow. He says "Manufactured housing has been recognized by legislatures on both sides of the aisle as a potential solution to the coming affordable housing crisis." That's a general statement. He talks about expansions: "We have broken ground on several of our expansions and anticipate completing 305 sites this year." That's about their own expansion. He says "Our acquisition pipeline currently consists of five properties containing 2,000 sites, with a blended occupancy rate of 66% for a total of $78 million." That's a pipeline, not current activity. He says "Many private funds are competing for deals, resulting in continued cap rate compression. Success breeds success. We expect our positive earnings growth to drive our share price higher, reducing our cost of capital. This will make more acquisitions available to us." That's about future. He says "Our successful community expansions will demonstrate to local government that UMH has the expertise required to build new communities that will help them solve the affordable housing crisis." That's about future.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
HROW · Q4 2021 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript shows management describing Harrow as already inside the large cataract surgery market (4.5–6 million procedures annually) with real, present-tense participation: thousands of customer relationships, shipping north of two million sterile ophthalmic units last year, and touching roughly one million cataract surgeries. They explicitly contrast this scale against 2021 revenues of $72.5 million, noting that even a modest share of the pass-through-eligible market (1 million procedures × premium pricing) would produce “a big number” and drive revenues “more than double” in the near term. They treat the current business as only the “earliest sliver” of what they are already positioned inside, with the binding question being how much of the existing flow they can capture rather than whether the flow exists. This meets both criteria. The answer is YES. The transcript shows management describing Harrow as already inside the large cataract surgery market (4.
WRBY · Q1 2024 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript explicitly states that the company is already inside the optical industry with real business (245 stores serving customers, 83% of stores offering exams, 2.36 million active customers, and growing revenue from glasses, contacts, and exams). Management then draws the size contrast directly, noting that even the longer 900-store target "would still represent a small fraction of the 45,000 optical shops in the U.S." and that over 50% of major metro areas have only one store.
HSTM · Q3 2017 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...**YES** Management describes the company already being inside a much larger flow of activity (the 80 million-person healthcare workforce, of which 4.6 million are in post-acute settings) and explicitly treats the scale mismatch as the central point. They note their strong sales team is already a “steady contributor” to 4.